HSPA5 and breast carcinoma: Both intracellular (ER-localized) GRP78 and cell surface-expressed GRP78 play disease-promoting roles in the development/course of breast cancer (see Section 4.2) and are thought to be potential targets for treating or sensitizing mammary gland malignancies with certain GRP78-affecting agents (see Section 5.2).